Diabetic kidney clinical trials
WebBAY-94-8862/16244 - A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of … WebApr 11, 2024 · The number of people living with chronic kidney disease (CKD) is growing as our global population continues to expand. With aging, diabetes, and cardiovascular …
Diabetic kidney clinical trials
Did you know?
WebJan 14, 2024 · Methods In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 ... WebTRIDENT (Transformative Research in Diabetic Nephropathy) Aim: To understand the clinical and molecular basis of progressive diabetic kidney disease. Patient Population: …
WebOct 10, 2024 · 9 Clinical Research Services, Mannheim GmbH, Grenadierstrasse 1, D-68167, Mannheim, Germany. ... Background: Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes … Web20 hours ago · The analysis included 13 trials with >90 000 patients with or without diabetes as well as patients with heart failure and CKD patients with diabetic and nondiabetic kidney diseases. Not surprisingly, authors globally confirmed that, compared to placebo, being on an SGLT2 inhibitor reduces the risk of CKD progression by 37% and …
WebApr 13, 2024 · Therefore, a total of 8 groups of non-diabetic nephropathy patients with clinical data from 4 clinical trials were included in this meta-analysis after rigorous screening. Four studies met the predetermined criteria: EMPRA(NCT03078101), DIAMOND (NCT03190694), DAPA-CKD (NCT03036150), and EMPA-KIDNEY(NCT03594110). WebThe study is designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial will test the effects of low systolic blood pressure (SBP) goal of < 120 …
WebNov 20, 2024 · Diabetic Kidney Disease. Drug: MEDI3506 Drug: Placebo Drug: Dapagliflozin. Phase 2. Detailed Description: This is a Phase 2b, randomized, double …
WebPhase 2 Study of INV-202 in Patients With Diabetic Kidney Disease : Official Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, … diagnostics surgeryWebPhase 2 Study of INV-202 in Patients With Diabetic Kidney Disease : Official Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of Two Doses of INV-202 in Patients With Diabetic Kidney Disease ... National Institute of Clinical Research, Inc - El Monte [Recruiting] El Monte ... cinnaholic westdale hamiltondiagnostic stage is unembryonated ovumWebApr 14, 2024 · Major clinical trials using SGLT2 inhibitors have signalled a major advance in the treatment of CKD, especially in relation to type 2 diabetes, but the affordability, availability, and relevance to the African population is not established. ... Tuttle, K.R. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin. J. Am. Soc ... diagnostics settings on azure virtual machineWebApr 14, 2024 · Introduction: Bardoxolone methyl significantly increases estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD). However, the phase … cinnaholic westlake ohioWebAug 28, 2024 · Although previous trials have examined cardiovascular outcomes in patients with type 2 diabetes and varying degrees of CKD, there remains scant evidence from dedicated clinical trials to support ... diagnostic stage of brugia malayiWebApr 7, 2024 · Conclusions: Among patients with chronic kidney disease, regardless of the presence or absence of diabetes, the risk of a composite of a sustained decline in the estimated GFR of at least 50%, end ... diagnostic stage of paragonimus westermani